Circulating Tumor Cells (CTCs) in Advanced Gastric Cancer
|The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.|
|ClinicalTrials.gov Identifier: NCT01848015|
Recruitment Status : Unknown
Verified May 2015 by Shen Lin, Peking University.
Recruitment status was: Recruiting
First Posted : May 7, 2013
Last Update Posted : May 19, 2015
To assess the predictive value of circulating tumor cells (CTCs) for recurrence of advanced gastric cancer after radical resection.
To identify the relationship between the detection of circulation tumor cells and recurrence patterns of gastric cancer after radical resection.
|Condition or disease||Intervention/treatment|
|Gastric Cancer||Other: detection of CTCs|
|Study Type :||Observational|
|Estimated Enrollment :||200 participants|
|Official Title:||Prediction of Recurrence in Advanced Gastric Cancer After Radical Resection by Circulating Tumor Cells （CTCs）|
|Study Start Date :||June 2013|
|Estimated Primary Completion Date :||June 2016|
|Estimated Study Completion Date :||June 2016|
Other: detection of CTCs
- CTCs [ Time Frame: 2 months ]
- Recurrence of gastric cancer after radical resection [ Time Frame: 2 years ]
To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.
Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT01848015
|Contact: Lin Shen, MD,PhD||(86)firstname.lastname@example.org|
|Peking cancer hospital||Recruiting|
|Beijing, Beijing, China, 100142|
|Contact: Ming Lu, MD (86)10-88196561 email@example.com|
|Principal Investigator:||Lin Shen, MD, PhD||Peking University|